GB
Gil Blum Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
125
Avg Return
Past Year
Past Year
4.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
95.5%
Neutral
4.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $16 |
174%
upside
| 1 | +13% |
0
%
| 4 Dec ‘25 yesterday |
|
|
|
Buy
Maintained
| $7 |
99%
upside
| 1 | +3.1% |
0
%
| 13 Nov ‘25 22 days ago |
|
|
|
Buy
Maintained
| $80 |
41%
upside
| 2 | +6.4% |
0
%
| 10 Nov ‘25 25 days ago |
|
|
|
Buy
Suspended
| $15 |
185%
upside
| 1 | -6.8% |
0
%
| 7 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $4 |
210%
upside
| 1 | -17% |
0
%
| 5 Nov ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $26 |
45%
upside
| 3 | +3% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $6 |
450%
upside
| 1 | -22% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $10 |
554%
upside
| 2 | -2.1% |
0
%
| 3 Nov ‘25 1 month ago |
|
|
|
Hold
Reiterated
| – | – | 1 | – |
–
| 27 Oct ‘25 1 month ago |
|
|
|
Buy
Suspended
| $6 |
46%
upside
| 2 | +46% |
0
%
| 24 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $70 |
34%
downside
| 2 | +44% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $10 |
92%
upside
| 2 | +21% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $18 |
431%
upside
| 1 | +3.9% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $14 |
41%
upside
| 1 | +25% |
0
%
| 18 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $8 |
69%
upside
| 1 | -4.5% |
0
%
| 11 Sep ‘25 2 months ago |
|